Comparing two local anaesthetic drugs in treatment of children's teeth

ISRCTN ISRCTN11415977
DOI https://doi.org/10.1186/ISRCTN11415977
EudraCT/CTIS number 2011-004711-23
Secondary identifying numbers DT11/9936
Submission date
17/09/2012
Registration date
12/10/2012
Last edited
15/10/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Oral Health
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Studies have found that the anaesthetic articaine is more effective and has comparable safety to the anaesthetic lidocaine when used as in routine dental treatments on permanent teeth in adults. However, as far as we are aware there no studies have been conducted to compare the effectiveness of articaine to lidocaine during dental treatment of children’s primary molar teeth (i.e., milk teeth). Therefore, the aim of this study is to compare the anaesthetic effectiveness of articaine and lidocaine in the dental treatment of primary molars in children aged 5-9. We will also evaluate the response of children when they receive the local anaesthetic injection, in order to recommend the most effective and acceptable method of injection.

Who can participate?
Children aged 5-9 who are attending Leeds Dental Hospital for dental treatment.

What does the study involve?
Participants are randomly allocated into two groups. One group is treated with articaine and the other group is treated with lidocaine. The child’s reaction to the injection is assessed by asking them to rate the pain, discomfort and numbness. The acceptability of the treatment is assessed using a questionnaire.

What are the possible benefits and risks of participating?
The participant may not personally benefit but we are hoping to find out which is the most effective treatment for future use. The risks are the same as any other routine dental treatment, including pain, discomfort, strange feeling of numbness, and lip or cheek biting.

Where is the study run from?
Leeds Dental Institute, University of Leeds (UK).

When is the study starting and how long is it expected to run for?
January 2013 to September 2015.

Who is funding the study?
University of Leeds (UK).

Who is the main contact?
Dr Fatma Alzahrani

Contact information

Prof Monty Duggal
Scientific

Consultant and Head of Paediatric Dentistry
University of Leeds
Child Dental Health
Leeds Dental Institute
Clarendon Way
Leeds
LS2 9LU
United Kingdom

Study information

Study designParallel prospective randomised control trial
Primary study designInterventional
Secondary study designRandomised parallel trial
Study setting(s)Other
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information
Scientific titleComparative studies of the anaesthetic efficacy of 4% Articaine with 1:100,000 epinephrine used as mandibular infiltration versus 2% Lidocaine with 1:80,000 epinephrine used as inferior dental nerve block, in extraction and restoration of mandibular primary molars
Study objectivesThere is no difference in the pain experience between mandibular infiltration using 4% articaine with 1:100,000 epinephrine and the conventional technique inferior alveolar nerve block using 2% lidocaine with 1:80,000 epinephrine in dental treatment of mandibular primary molars.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedDental caries
InterventionWe will randomly assign the subjects into 2 groups; one group (Treatment group) will receive mandibular infiltration with 4% articaine with 1:100,000 and the other group (Control group) will receive inferior alveolar nerve block with 2% lidocaine with 1:80,000.

All local anaesthetic injections will be given by a single operator ,who will assess the child behaviour during the injection procedures (using Frankl Behaviour Scale). Each child will receive one treatment for one tooth only. The assessment will be done during all the procedures.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Articaine, Lidocaine
Primary outcome measureSuccessful completion of treatment
Secondary outcome measures1. Child perception of the treatment using specific questionnaire developed by the researcher
2. Parent perception of the treatment using specific questionnaire developed by the researcher
Overall study start date01/01/2013
Completion date01/09/2015

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit5 Years
Upper age limit9 Years
SexBoth
Target number of participants110
Total final enrolment98
Key inclusion criteria1. Children aged 5 to 9 years
2. Medically fit
3. Requiring extraction /restoration of primary mandibular molars teeth under local anaesthetic
4. Understand English
5. Mentally capable of communication
6. Tooth has no history of infection (abscess) or swelling and no evidence of periapical pathosis
7. The roots resorption of the primary tooth must be less than half of the root
8. Parents/guardian must give informed written consent prior to participation
9. Child must give assent form prior to participation, as well as parental consent
Key exclusion criteria1. Medically and mentally compromised children
2. History of significant behaviour management problems
3. Evidence of infection near the proposed injection site as this might affect the efficacy of local anaesthesia
4. Child does not speak English
Date of first enrolment01/01/2013
Date of final enrolment01/09/2015

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

University of Leeds
Leeds
LS2 9LU
United Kingdom

Sponsor information

University of Leeds (UK)
University/education

Leeds Dental Institute
Clarendon Way
Leeds
LS2 9LU
England
United Kingdom

Website http://www.leeds.ac.uk/
ROR logo "ROR" https://ror.org/024mrxd33

Funders

Funder type

University/education

University of Leeds (UK) ref: DT11/9936
Private sector organisation / Universities (academic only)
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/05/2018 15/10/2020 Yes No

Editorial Notes

15/10/2020: Publication reference and total final enrolment number added.
31/05/2019: Internal review.
24/01/2018: No publications found in PubMed, verifying study status with principal investigator.